Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

First Irish customer for Kainos Evolve

6 Jul 2017 07:00

RNS Number : 2494K
Kainos Group plc
06 July 2017
 

RNS Reach

Kainos Group plc

 

Kainos Evolve® to provide Electronic Document and Records Management solution to first Irish customer at Saolta University Health Care Group

 

Belfast/London - 6 July, 2017 - Kainos Group plc (KNOS), a leading provider of digital services and platforms, announces that its healthcare division, Kainos Evolve, has signed a deal with the Health Service Executive of Ireland and Saolta University Health Care Group in Galway for the provision of the Kainos Evolve Electronic Medical Record (EMR) solution. The contract is for three years, with provision for a further two year extension.

Evolve is the leading clinical document management platform in the UK, selected by 35 NHS Trusts and in use in 110 hospitals, covering notes and images for over 33 million patients. This new engagement with Saolta represents Kainos Evolve's first deal in Ireland.

Evolve will be implemented in a phased approach across Saolta's entire 3,000-member clinical user base. The project will accommodate mobile access via Evolve's solution for iPad, management of incoming patient referrals and onward patient flow, clinical quality management and integration with imaging systems. By deploying these components, Kainos Evolve has the potential to transform the efficiency and effectiveness of care across the entire Saolta University Health Care Group and partner organisations.

Brendan Mooney, CEO of Kainos Group, commented: "I'm pleased to announce this first contract win for Kainos Evolve in Ireland. This is testament to the quality of our offerings and the investment that we have in our healthcare platforms in recent years. There is a large addressable market for Evolve and we remain committed to enhancing our offering and making further in-roads in Ireland and across the UK."

- ENDS -

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Brian Gannon, SVP Corporate Development

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon/Chris Lane/Nicola Krafft

 

 

About Kainos

 

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms. The Group's Digital Platforms comprise specialised digital products for mobilehealthcare and automated testing. Kainos Evolve Electronic Medical Records (EMR) and Integrated Care (IC) platforms provide a comprehensive suite of digital services to healthcare providers such as hospitals and ambulatory care organisations. Kainos employs approximately 1,000 staff across eight offices in Europe and the USA, and is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFFRDRIEIID
Date   Source Headline
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.